快而精医药 QGEN 深 沪
等待开盘 05-27 09:30:00 美东时间
35.54
+0.370
+1.05%
华盛通- 最 高35.56
- 今 开35.29
- 成交量 153.28万股
- 最 低 35.09
- 昨 收 35.17
- 总市值 733.01万
- 52周最高 57.815
- 市盈率 静 17.39
- 换手率 743.20%
- 52周最低 32.53
- 委 比 34.00%
- 总股本 0.00亿
- 历史最高 60.3887
- 量 比 0.79
- 振 幅 1.34%
- 历史最低 7.7822
- 每 手 1
- 风险率 4.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
Stifel Maintains Hold on Qiagen, Lowers Price Target to $36
Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target from $50 to $36.
05-19 00:53
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
QIAGEN Plans To Advance QuantiFERON Latent TB Test With Automated Sample To Insight Workflow And Separate AI-Enabled Risk Stratification Tool For TB Progression
Ambition to support high-throughput laboratories in efficiently scaling latent tuberculosis (TB) screening as testing volumes continue to growFully automated workflow targeted for late 2027 launch integrates QuantiFERON
05-07 18:06
UPDATE: Qiagen FY2026 expected to be more than $2.43 vs $2.51 Est; Affirms FY2026 Sales Guidance of $2.111B-$2.132B vs $2.183B Est
Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.43 vs $2.51 Est. affirms FY2026 sales outlook from $2.111 billion-$2.132 billion to $2.111 billion-$2.132 billion vs $2.183 billion estimate.
05-07 05:48
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
This Crane Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Analysts upgraded Qiagen, Armstrong World, T-Mobile, Crane Co, and Centene Corp stocks, with price target changes. See their ratings and views.
04-29 19:35
Baird Upgrades Qiagen to Outperform, Lowers Price Target to $43
Baird analyst Catherine Schulte upgrades Qiagen (NYSE:QGEN) from Neutral to Outperform and lowers the price target from $53 to $43.
04-29 17:19
Stock Market Today: S&P 500 Drops Amid Tech Sell-Off, Oil Climbs To $100 On Hormuz Drama
Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies above $99 and the Fed's two-day meeting kicks off.
04-29 03:43
